Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating infectious pleuropneumonia of swine and preparation method thereof

A technology of pleuropneumonia and composition, which is applied in the field of pharmacy, can solve the problems of ineffective clinical treatment and achieve the effects of no toxic side effects, fast onset and high safety

Inactive Publication Date: 2015-01-21
SHANDONG NEW HOPE LIUHE GROUP
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although many antibiotics are reported to be effective, the clinical effect of this disease is not obvious due to the resistance of bacteria

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for treating infectious pleuropneumonia of swine and preparation method thereof
  • Pharmaceutical composition for treating infectious pleuropneumonia of swine and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0058] Example 1 Granules

[0059] The embodiment of the present invention provides a pharmaceutical composition for treating porcine contagious pleuropneumonia. 18 parts by weight of Houttuynia cordata, 25 parts by weight of honeysuckle, 14 parts by weight of paeonol, 15 parts by weight of seaweed stone, 28 parts by weight of dried ginger, 20 parts by weight of almond, 17 parts by weight of blue eucalyptus, 12 parts by weight of gardenia, 14 parts by weight of raw ground 18 parts by weight of Dawanhua, 20 parts by weight of light tempeh, 27 parts by weight of reed root, 15 parts by weight of Sijiqing, 10 parts by weight of leek, 17 parts by weight of ghost needle grass, 13 parts by weight of Malan, 15 parts by weight of pear peel Parts, 15 parts by weight of ginger shells, 17 parts by weight of fennel, 14 parts by weight of Tricholoma, 20 parts by weight of coltsfoot, 15 parts by weight of roses, 12 parts by weight of radish, 20 parts by weight of cardamom, 15 parts by weigh...

Embodiment 2

[0063] Embodiment 2 injection

[0064] The embodiment of the present invention provides a pharmaceutical composition for treating porcine contagious pleuropneumonia. 16 parts by weight of Houttuynia cordata, 23 parts by weight of honeysuckle, 16 parts by weight of paeonol, 13 parts by weight of seaweed stone, 25 parts by weight of dried ginger, 23 parts by weight of almond, 16 parts by weight of blue eucalyptus, 13 parts by weight of gardenia, 15 parts by weight of raw ground 16 parts by weight of Dawanhua, 18 parts by weight of light tempeh, 26 parts by weight of reed root, 17 parts by weight of Sijiqing, 13 parts by weight of leek, 15 parts by weight of ghost needle grass, 12 parts by weight of Malan, 16 parts by weight of pear peel . 17 parts by weight of perilla, 16 parts by weight of bellflower, 13 parts by weight of malt and 14 parts by weight of Hericium erinaceus.

[0065] Its preparation method comprises the following steps:

[0066] In the first step, the raw med...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention discloses a pharmaceutical composition for treating infectious pleuropneumonia of swine and a preparation method thereof. The pharmaceutical composition comprises the following raw medicinal materials: golden cypress, Scutellaria baicalensis, Houttuynia cordata, honeysuckle, cortex moutan, seaweed stone, rhizoma zingiberis, almond, blue gum, jasmine, root of rehmannia, Calystegia hedera, fermented soybean, rhizoma phragmitis, leaf of purpleflower holly, Allium caeruleum, sticktight, Indian Kalimeris herb, bretschneider pear pericarp, dried scallop (adductor), trichosanthes kirilowii Maxim, dried mushroom from Zhangjiakou, flos farfarae, rose, semen raphani, siberian nitraria fruit, Indian rorippa herb, common perilla fruit, Platycodon grandiflorum, malt and hericium erinaceus. The pharmaceutical composition has the beneficial effects that the theory of traditional Chinese medicine is utilized, the holistic view is taken as the basis, treatment based on syndrome differentiation is taken as guidance, the effects of clearing away heat and purging pathogenic fire, detoxifying and relieving a cough are taken as main treatment principles, the effects of tonifying spleen and regulating vital energy are taken as auxiliary principles, and the pharmaceutical composition is used for treating infectious pleuropneumonia of swine and has the advantages of fast effectiveness, exact curative effect, high safety and zero toxic or side effect.

Description

technical field [0001] The invention relates to the technical field of pharmacy, in particular to a pharmaceutical composition for treating porcine infectious pleuropneumonia and a preparation method thereof. Background technique [0002] Porcine infectious pleuropneumonia is a contagious disease caused by Actinobacillus pleuropneumoniae. It is an important respiratory disease of pigs. It is prevalent in many pig-raising countries and has become one of the five major diseases of industrialized pigs in the world. cause significant economic losses. Antibiotics have no obvious effect on this disease. Although extensive and in-depth research has been done on the disease and its pathogenic bacteria, and certain achievements have been made in vaccines and diagnostic methods, so far, there are no effective measures to control the disease. [0003] The pathogen is Actinomyces pleuropneumoniae (formerly known as Haemophilus pleuropneumoniae, also known as Haemophilus parahaemolytic...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/9068A61P31/04A61K33/00
CPCA61K36/756A61K9/0014A61K9/08A61K9/1652A61K35/618A61K36/04A61K36/06A61K36/185A61K36/19A61K36/28A61K36/31A61K36/34A61K36/355A61K36/39A61K36/428A61K36/47A61K36/48A61K36/535A61K36/539A61K36/56A61K36/61A61K36/704A61K36/71A61K36/73A61K36/736A61K36/738A61K36/744A61K36/78A61K36/80A61K36/804A61K36/8962A61K36/899A61K36/8998A61K36/9068A61K2236/30A61K2236/333A61K2300/00
Inventor 吕尊周吕明斌燕磊
Owner SHANDONG NEW HOPE LIUHE GROUP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com